11 - 14 March 2026 - Congress contribution
13 - 16 May 2026 - Congress contribution
"Revolution der Mittel – Realität der Menschen."
05 - 08 June 2026 - Congress contribution
At this year's Diabetes Congress, not only Dr. Freckmann was invited as a speaker, but also Dr. Pleus, who gave two presentations on CGM standardization and on POCT glucose measurement systems and the updated Rili-BÄK. Dr. Freckmann also gave two presentations on the future of CGM systems in hospitals and the current quality standards for CGM systems. In addition, Dr. Waldenmaier gave a poster presentation on our own research on the performance evaluation of current CGM systems.
At this year's EuroMedLab Congress, Dr. Freckmann gave a presentation on the traceability of CGM systems and the importance of standardized study protocols for the validation of CGM systems in the clinical environment.
At this year’s Diatec, Dr. Freckmann gave a presentation focusing on the quality of glucose measurement of CGM systems.
This year, the Diabetes Technology Meeting took place in person again after a long time. A good opportunity to finally present the results of our self-initiated CGM performance study! In this study, we evaluated the feasibility of the study procedures proposed by the IFCC WG-CGM and also tested the current CGM systems of the three largest manufacturers in parallel. With both, we have aroused a lot of interest and can help the IFCC WG-CGM on its way to standardizing CGM. We were also able to present further posters on the topics of CGM accuracy, usability and smartwatches.
At the POCT symposium at the DKLM, together with Dr Rolf Hinzmann from the IFCC working group, we were able to fill an entire symposium on the topic of CGM and standardization. We were also allowed to present the results of our analyses of the new, stricter quality control limits in the Rili-BÄK. Dr Freckmann, Dr Eichenlaub and Dr Pleus from the IfDT team were present.
The conference president, Prof. Dr. Claudia Eberle (Fulda), and the board of the AGDT, Dr. Guido Freckmann (Ulm), Dr. Sandra Schlüter (Nordheim) and Dr. Tobias Wiesner, can look back on a successful annual conference of the AGDT (Diabetes & Technology Working Group) at Fulda University of Applied Sciences. Under the motto “Insulin control, algorithms and AI - what does this mean for practice?”, not only apps and DiGAs, but also automatic insulin dosing (AID) in pregnancy and standards for glucose measurement played a central role.
As part of the event, Dr Stefan Pleus spoke on the topic of “CGM: standardization and measurement accuracy”.
In addition to a poster presentation on the topic of characterizing hypoglycemia with CGM, we also gave two presentations on the topics of CGM performance and standardization.
Not only was Dr. Freckmann invited to speak at this diabetes congress, but our Dr. Anne Beltzer was also able to give a presentation on the topic of usability in front of a large audience. We were also allowed to present three posters - all contributions from our self-initiated and self-financed research. Dr. Annette Baumstark was even awarded a poster prize for her contribution "Investigation of the internal quality control of blood glucose measurement systems with unit-use reagents and intended purpose for professional use, taking into account the updated requirements of the Rili-BÄK". Congratulations!
Our summary of the ATTD in Florence: One lecture in the main program, 4 e-posters with IfDT co-authorship and many important discussions.
At this year's Diatec Congress in Berlin, which was entitled "AI in technology", Dr. Freckmann was a speaker on the topic of "Measurement accuracy of CGM systems". He also presented our latest findings on smartwatches that promise non-invasive glucose monitoring. They delivered the identical blood glucose curves in our self-experiment with humans and bananas. This makes in our belief all further questions about measurement accuracy obsolete...
This year, the JA-PED took place in our home town Ulm. Although we were not represented in the scientific program this time, we were present with our small diabetes technology museum.
At this annual Diabetes Technology Meeting, which was still completely virtual, we were again mainly representing the topic of CGM standardization. At the pre-meeting on November 1, the IFCC working group even had its own symposium. Dr. Freckmann and Dr. Pleus presented the results of the IFCC working group's latest publications. John Pemberton and Dr. Rolf Hinzmann were also invited to contribute. In the main meeting on November 2, Dr. Eichenlaub presented our newly developed method of displaying CGM accuracy - CG-DIVA.
The annual conference of the Diabetes and Technology Working Group of the German Diabetes Society (AGDT) took place on September 22 and 23, 2023 under the motto "Technology - Together. From practice for practice". Dr. Freckmann has been a member of the AGDT board for several years and made the institute's grounds and rooms available for the conference. The conference was attended by a total of around 110 participants. Dr. Freckmann gave a lecture on "CGM in hospitals - data and legal issues" and took part in the scientific exchange with some colleagues.
The American Society for Clinical Chemistry invited Dr. Freckmann to give two lectures. "Continuous glucose monitors in the hospital: Are they good enough?" and "Standardization process of Continuous Glucose Monitoring: Traceability and Performance". The flight to Anaheim was well worth it.
Again this year, Dr. Freckmann was invited to the 83rd Congress of the American Diabetes Association in San Diego. At the joint symposium of the ADA and AACC, the American societies for diabetes and clinical chemistry, Dr. Freckmann gave a lecture on "Continuous Glucose Monitors in the Hospital-Are They Good Enough?".
At the 57th Diabetes Congress in Berlin under the motto "Rethinking Diabetes - Diversity & Individuality", Dr. Freckmann chaired several sessions and spoke on the topic of "Quality of glucose measurement with CGM systems - Are standards necessary?". As a member of the program committee, he was also involved in actively shaping the program.
This year's International Conference on Advanced Technologies and Treatments of Diabetes (ATTD) was held February 22-25 at the CityCube in Berlin. A major focus of the symposia was on the potential benefits of continuous glucose monitoring (CGM) in people with type 2 diabetes.
Dr. Freckmann gave a presentation on Friday, February 24, 2023, on standardization related to CGM systems. In doing so, he presented the current status of the IFCC working group's activities on CGM.
From 26 to 28 January 2023, the training event diatec took place in Berlin under the main theme "Personalized Technology". Some of our colleagues took the opportunity to learn about the current state of research in diabetes technology in various lectures, seminars and symposia.
Dr. Guido Freckmann, as part of the diatec team, actively participated in the organization of the conference and gave lectures on "CGM in hospitals" and "Glucose measurement in type 2 diabetes". He also led a seminar on "Safety issues in medical devices".
From November 24 to 26 the joint autumn meeting of the German Diabetes Association and the German Angiology Association took place in Wiesbaden. Our colleagues were actively involved in the sessions of the committee for laboratory diagnostics in diabetology of the DDG and DGKL (KLD), as well as of the working group diabetes and technology of the DDG (AGDT).
In the KLD session, Dr. Stefan Pleus talked about the basics of the guidelines of the German Medical Association for quality assurance in medical laboratories (Rili-BÄK) and Dr. Guido Freckmann finished the session with his critical talk on the topic "New measurement methods - new rules?".
Dr. Stefan Pleus also contributed a talk about the basics of blood glucose monitoring, continuous glucose monitoring and insulin pumps used in automated insulin delivery systems in the AGDT session on AID systems in practice.
From November 3 to 5 the 22nd Diabetes Technology Meeting of the Diabetes Technology Society took place. One again, the conference was held virtually.
Dr. Freckmann was invited to give a talk about “Traceability of CGMs” in Workshop A (Measurement of glucose, insulin and ketones) and presented the current work of the IFCC working group on CGM (IFCC WG-CGM) regarding standards for continuous glucose monitoring.
All of our three abstracts that we submitted for the poster session one week later on November 10 were accepted. Dr. Stefan Pleus presented two posters in session C. In his contribution „User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems with Color Coding of Results“ he showed results from our latest blood glucose monitoring system evaluation and in his contribution “Improving the Quality of Glucose Concentration Measurements by Recalibration” he presented our suggestion for improvement of comparison measurements, e.g. in CGM studies. Dr. Manuel Eichenlaub introduced a new method to evaluate and present CGM accuracy in his contribution „The Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): An illustrative Method for Continuous Glucose Monitoring System Accuracy Assessment“.
Two of the three posters were developed within our cooperation with the Diabetes Center Berneto support the work of the IFCC WG-CGM. Thanks to all contributors!
Poster abstracts will be published in the March issue of the des Journal of Diabetes Science and Technology.
On October 13 and 14, the joint 17th annual meeting of the German Association for Clinical Chemistry and Laboratory Medicine and 4th meeting for biomedical analytics of the DVTA was held in Mannheim. Under the general topic "Laboratory medicine accompanies life" we presented two posters about studies on our own initiative with the titles „Fasting plasma glucose concentrations in different sampling tubes measured with different glucose analyzers“ and „Differences between venous, capillary and interstitial glucose concentrations during an oral glucose tolerance test”. In addition, Dr. Guido Freckmann was invited to talk about "Continuous Glucose Monitoring CGM - Traceability and Standards" in the session "Point-of-care laboratory diagnostics - An Update".
To improve the reader-friendliness of our website, we use the generic masculine. In the context of equal treatment, we would like to point out that the content of our website is aimed at all genders and does not contain any valuation.
Privacy policy settings
Cookie settings
This website uses cookies that enable you to use services offered by external providers, such as YouTube or Google Maps. The legal basis here is Art. 6 DSGVO (1) a.
Here you can object to the anonymized recording of your user behavior by MATOMO. For this purpose, we store a cookie on your computer to respect this decision also on subsequent visits.
Please note that depending on your settings, some functions may not be available.
You can find more information in our Privacy policy
